CHEST® Journal

Peyerl - Figure 20

Cumulative 5 year Savings for 1,000 qualified COPD patients for NIPPV (AVAPS-AE) versus No NIV

In summary, in Figure 20 we see that over the 5-year period for the 1000 hypothetical patients in this budget impact analysis (BIM), for the different stakeholders there is a cost avoidance to the hospital of just over $5 million and a revenue generation to the DME provider approaching $30 million, with the payer avoiding costs in excess of $15 million over the 5-year period.  

Peyerl F. Chest 2016:00.